Back
Novo Nordisk A/S Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
NVO
Novo Nordisk A/S
Last Price:
$52.50
Seasonality Move:
4.04%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing slight selling pressure.
Novo Nordisk A/S Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.09 | Buy |
| 20-day SMA: | 48.48 | Buy |
| 50-day SMA: | 49.71 | Buy |
| 200-day SMA: | 60.54 | Sell |
| 8-day EMA: | 49.07 | Buy |
| 20-day EMA: | 48.78 | Buy |
| 50-day EMA: | 50.2 | Buy |
| 200-day EMA: | 62.83 | Sell |
Novo Nordisk A/S Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 60.1 | Buy |
| Chaikin Money Flow: | -31905611 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.86 - 49.64) | Buy |
| Bollinger Bands (100): | (48.21 - 56.95) | Sell |
Novo Nordisk A/S Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Novo Nordisk A/S Stock
Is Novo Nordisk A/S Stock a Buy?
-
Novo Nordisk A/S share price is 51.61 while NVO 8-day simple moving average is 49.09, which is a Buy signal.
-
The stock price of NVO is 51.61 while Novo Nordisk A/S 20-day SMA is 48.48, which makes it a Buy.
-
Novo Nordisk A/S 50-day simple moving average is 49.71 while NVO share price is 51.61, making it a Buy technically.
-
NVO stock price is 51.61 and Novo Nordisk A/S 200-day simple moving average is 60.54, creating a Sell signal.
NVO Technical Analysis vs Fundamental Analysis
Sell
36
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy or a Sell?
-
Novo Nordisk A/S stock is rated a SellThe current Novo Nordisk A/S [NVO] share price is $51.61. The Score for NVO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Novo Nordisk A/S Stock Info
Market Cap:
229.3B
Price in USD:
51.61
Share Volume:
67.6M
Novo Nordisk A/S 52-Week Range
52-Week High:
93.80
52-Week Low:
43.08
Sell
36
Novo Nordisk A/S (NVO)
is a Sell
Novo Nordisk A/S Share Price Forecast
-
What is the Novo Nordisk A/S stock price today?The Novo Nordisk A/S stock price is 51.61 USD today.
-
Will NVO stock go up or go down?Novo Nordisk A/S> share price is forecast to RISE/FALL based on technical indicators
-
Is Novo Nordisk A/S overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Novo Nordisk A/S is overvalued.
Is Novo Nordisk A/S Stock a Buy?
-
Novo Nordisk A/S share price is 51.61 while NVO 8-day exponential moving average is 49.07, which is a Buy signal.
-
The stock price of NVO is 51.61 while Novo Nordisk A/S 20-day EMA is 48.78, which makes it a Buy.
-
Novo Nordisk A/S 50-day exponential moving average is 50.20 while NVO share price is 51.61, making it a Buy technically.
-
NVO stock price is 51.61 and Novo Nordisk A/S 200-day simple moving average is 62.83, creating a Sell signal.
Fundamental Analysis of Novo Nordisk A/S
Is Novo Nordisk A/S a good investment?
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and a decrease next year of $0.17 per share.
Technical Analysis of Novo Nordisk A/S
Should I short Novo Nordisk A/S stock?
-
NVO Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Novo Nordisk A/S is a Sell
-
Novo Nordisk A/S Relative Strength Index (RSI) is 60.1, which suggest Novo Nordisk A/S is overbought
-
The Bollinger Bands (25) for Novo Nordisk A/S is (46.86 - 49.64), which suggest Novo Nordisk A/S is a Sell
-
The Bollinger Bands (100) for Novo Nordisk A/S is (48.21 - 56.95), which suggest Novo Nordisk A/S is a Sell
* Novo Nordisk A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.